Quantum Genomics S.A.
QNNTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $3 | $6 |
| % Growth | -99.9% | -99.2% | -56.6% | – |
| Cost of Goods Sold | $1 | $1 | $30 | $20 |
| Gross Profit | -$1 | -$1 | -$27 | -$17 |
| % Margin | -11,453,070% | -7,169.6% | -1,073% | -296.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $17 |
| SG&A Expenses | $0 | $2 | $3 | $17 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$14 |
| Operating Expenses | $0 | $2 | $3 | $3 |
| Operating Income | -$1 | -$3 | -$30 | -$17 |
| % Margin | -14,728,350% | -15,847.9% | -1,196.1% | -294.7% |
| Other Income/Exp. Net | -$7 | -$0 | $3 | -$0 |
| Pre-Tax Income | -$9 | -$3 | -$27 | -$17 |
| Tax Expense | $0 | -$0 | -$3 | $0 |
| Net Income | -$9 | -$3 | -$25 | -$17 |
| % Margin | -88,926,030% | -16,018.1% | -991.4% | -299.3% |
| EPS | -0.13 | -0.091 | -0.72 | -0.61 |
| % Growth | -42.9% | 87.4% | -18% | – |
| EPS Diluted | -0.13 | -0.091 | -0.72 | -0.61 |
| Weighted Avg Shares Out | 70 | 35 | 35 | 27 |
| Weighted Avg Shares Out Dil | 70 | 35 | 35 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$3 | -$30 | -$19 |
| % Margin | -14,702,370% | -14,515.5% | -1,185.6% | -334.7% |